Last reviewed · How we verify
NCT03411889
A Feasibility Study to Develop a Protocol for Functional Lacrimal Magnetic Resonance Imaging
NA trial testing MRI scanning in Lacrimal Duct Obstruction in 15 participants. Completed in 31 March 2019.
31 March 2019
Quick facts
| Lead sponsor | Brighton and Sussex University Hospitals NHS Trust |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 15 |
| Start date | 13 June 2018 |
| Primary completion | 31 March 2019 |
| Estimated completion | 31 March 2019 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- MRI scanning
Conditions studied
- Lacrimal Duct Obstruction — all drugs for Lacrimal Duct Obstruction →
- Lacrimal Stenosis — all drugs for Lacrimal Stenosis →
Sponsor
Brighton and Sussex University Hospitals NHS Trust
Who can join
18 and older, any sex, with Lacrimal Duct Obstruction or Lacrimal Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Watering eyes (epiphora) is a very common ophthalmic condition. It is frequently caused by dysfunction of the lacrimal (tear) drainage system which is the 'pipework' that takes tears from the eye to the nasal cavity. If the system is completely blocked then the patient is offered surgery to unblock or bypass the obstruction. However, the system is often either partially obstructed, or there is tear drainage delay despite there being no apparent obstruction (functional obstruction). Currently this is investigated with two separate scans, conducted at different times in different departments (CT and nuclear medicine). These are dacryocystography (DCG) and dacryoscintigraphy (DSG) and both are required as they have different limitations and benefits. Moreover DCG is a CT scan that uses radiation. Functional magnetic resonance dacryocystography (MR DCG) is increasingly widely used in other fields of medicine (e.g. cardiology) because of the increasing acquisition speed and resolution of MRI scanners in recent years. The investigators anticipate functional MRI of the lacrimal drainage system (i.e. scanning as eye drops are instilled and pass down the system) will overcome the shortcomings of DCG and DSG, by simultaneously providing both good anatomical detail and physiological images. Various methods of MR DCG have been described in the literature and there is no standard protocol for this procedure as of current. In this study, the investigators aim to develop a protocol for MR DCG that can be used in routine radiological practice in place of DCG and DSG and get pilot data on tear drainage in participants with known delayed tear drainage and controls with normal tear drainage systems.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03411889
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MRI scanning
Trials testing the same drug.
- NCT04862572 — Investigating Disinhibitory Brain Mechanism in Tinnitus and Hearing Loss · NA · completed
- NCT02603640 — " Virtual Brain "-Based Interpretation of Electrophysiological Signals in Epilepsy · NA · completed
Other Brighton and Sussex University Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT06120946 — Neurocognitive Assessment in TAVI · completed
- NCT05287269 — Ocular Coherence Tomography During Cataract Assessment · completed
- NCT04175951 — Tecnis Eyhance Versus Rayner RayOne Study · NA · unknown
- NCT04011696 — Monofocal Extended Range of Vision (MERoV) Study · completed
- NCT05671016 — Brain Imaging to Predict Toxicity in Elderly Patients After Radiotherapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03411889 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brighton and Sussex University Hospitals NHS Trust
- Last refreshed: 25 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03411889.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing